The latest report by IMARC Group, titled “Peptide Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“. The global peptide therapeutics market size reached US$ 39.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 66.1 Billion by 2028, exhibiting a growth rate (CAGR) of 9% during 2023-2028.
Peptide therapeutics are a class of drugs composed of short chains of amino acids, known as peptides, which play a crucial role in various biological processes within the human body. They are designed to target specific proteins, receptors, or enzymes involved in diseases and medical conditions. Unlike traditional small-molecule drugs, peptide therapeutics offer several advantages, such as high specificity and reduced off-target effects, making them particularly suitable for treating complex diseases like cancer, autoimmune disorders, and metabolic conditions. They can be engineered to mimic natural peptides or designed de novo to interact with specific biological targets. They are administered through numerous routes, including injection, oral delivery, or topical application, depending on the therapeutic target and desired outcomes. In recent years, peptide therapeutics have emerged as a rapidly evolving field in pharmaceutical research, with ongoing advancements in peptide synthesis techniques and drug delivery methods, making them promising candidates for innovative and targeted treatments in various medical conditions across the globe.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/peptide-therapeutics-market/requestsample
Peptide Therapeutics Market Trends and Drivers:
The global peptide therapeutics market is primarily driven by the rising demand for targeted and personalized treatments due to the growing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders. Apart from this, ongoing advancements in peptide synthesis and formulation techniques that expand the range of therapeutic peptides available and improve their stability and bioavailability have catalyzed market growth. Additionally, the aging population and the escalating need for innovative treatment options are supporting market growth. Besides this, the increasing biotechnology and pharmaceutical research and development (R&D) activities is fueling the discovery and development of novel peptide-based drugs, thereby fostering market growth. Moreover, the potential for fewer side effects and better efficacy than traditional medications has accelerated the adoption of peptide therapeutics. Along with this, regulatory approvals and a supportive reimbursement landscape represent another major growth-inducing factor. Furthermore, the heightening importance of peptide-based vaccines and antiviral drugs amid the coronavirus (COVID-19) pandemic is contributing to market growth.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Type:
- Innovative
- Generic
Breakup by Type of Manufacturer:
- Outsourced
- In-house
Breakup by Synthesis Technology:
- Solid Phase Peptide Synthesis
- Liquid Phase Peptide Synthesis
- Hybrid Technology
Breakup by Routes of Administration:
- Parenteral
- Oral
- Others
Breakup by Application:
- Gastrointestinal Disorders
- Neurological Disorders
- Metabolic Disorders
- Cancer
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Amgen Inc.
- Apitope International NV
- Arch Biopartners Inc.
- AstraZeneca plc
- Circle Pharma Inc.
- Corden Pharma GmbH
- F. Hoffmann-La Roche AG
- Ipsen Group
- Lonza Group AG
- Novo Nordisk A/S
- Pfizer Inc.
- Teva Pharmaceuticals Industries Ltd.
- Zealand Pharma A/S.
Explore full report with table of contents:Â https://www.imarcgroup.com/peptide-therapeutics-market
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal
